URANIA DAFNI

Professor

National and Kapodistrian University of Athens

Greece

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Urania Dafni is a Professor at the National and Kapodistrian University of Athens, Greece. Her research focuses on oncology, with recent articles addressing topics such as acquired resistance in non-small cell lung cancer (NSCLC) and the dynamics of circulating tumor DNA (ctDNA). Additionally, she explores the implications of specific fusions in adenocarcinoma and the outcomes of metastatic solid tumors in various treatment settings.

Articles (5)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (2)

Cathal O'Brien

Clinical Senior Lecturer

Trinity College Dublin

IRELAND

View details

Javier De Castro

HEAD OF LUNG CANCER UNIT

La Paz University Hospital

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

URANIA DAFNI

Research Interests

Contact this professor

About

Articles (5)

A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance – The ETOP 15-19 ABC-lung trial

ctDNA dynamics and mechanisms of acquired resistance in patients treated with osimertinib with or without bevacizumab from the randomised phase II ETOP-BOOSTER trial

ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project

Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion–Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World Setting

The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study

Collaborators (2)

Cathal O'Brien

Javier De Castro

Make your next move.